The Role of the Infant Skin Barrier in Food Sensitisation: Trans-Epidermal Water Loss and Atopic Interventions

What Is the Infant Skin Barrier and Why Does It Matter for Food Allergy?

The infant skin barrier refers to the outermost protective layer of a newborn's skin — a complex structure designed to regulate moisture, resist environmental irritants, and prevent the entry of foreign substances into the body. In the context of allergy development, this barrier plays a far more significant role than many parents or carers may realise.

Research published over the past two decades has increasingly pointed to skin barrier dysfunction as a potential gateway for food sensitisation in early life. When the skin barrier is compromised — particularly in infants with eczema or atopic dermatitis — allergens such as peanut proteins, egg, or milk may be absorbed transcutaneously (through the skin) rather than via oral ingestion. This alternative route of exposure may prime the immune system in a way that encourages allergic rather than tolerogenic responses.

For families in London and across the UK with a history of atopy, understanding this pathway is not just academically interesting — it may have genuinely meaningful implications for how early sensitisation is monitored.

Understanding Trans-Epidermal Water Loss (TEWL): A Key Biomarker

Trans-epidermal water loss (TEWL) is the measurement of water that passively evaporates through the skin to the surrounding environment. It is widely used in dermatological and paediatric research as a reliable indicator of skin barrier integrity.

In healthy skin, the stratum corneum — the outermost epidermal layer — forms a tight seal that minimises water loss and prevents allergen penetration. In infants with elevated TEWL, this seal is functionally weakened, which may allow environmental and dietary allergens to interact with immune cells beneath the skin surface.

Key biomarkers and indicators associated with TEWL research in infants include:

• Elevated TEWL measurements at the antecubital fossa (inner elbow crease)
• Reduced filaggrin protein expression (associated with FLG gene mutations)
• Higher total serum IgE levels in early infancy
• Presence of sensitisation to common food allergens (peanut, egg, cow's milk)
• Early onset atopic eczema, particularly before 3 months of age

Practical Insight: Elevated TEWL in early infancy does not automatically mean a child will develop food allergies. However, it may suggest a higher risk profile that warrants closer monitoring and early discussion with an appropriate healthcare professional.

How Skin Barrier Dysfunction May Lead to Food Sensitisation

The pathway from skin barrier dysfunction to food allergy is sometimes described as the "outside-in hypothesis" of allergy development. This stands in contrast to the traditional view that food sensitisation occurs primarily through gastrointestinal exposure.

When filaggrin — a structural skin protein — is underproduced due to genetic variants (particularly FLG loss-of-function mutations), the skin becomes more permeable. This allows nano-scale food proteins present in the household environment (for example, peanut dust on surfaces, or milk proteins transferred through handling) to penetrate the skin and interact with antigen-presenting cells.

This distinction matters clinically. Infants sensitised through transcutaneous exposure — rather than through eating — may show IgE reactivity to a food before they have ever consumed it. This can sometimes be detected through allergy blood testing in older infants and children when there is a clinical concern.

Practical Insight: The presence of a filaggrin mutation or early eczema does not mean food allergy is inevitable. Many children with these risk factors do not go on to develop clinical food allergies.

Atopic Interventions: What the Research Suggests

The term atopic intervention refers to any strategy aimed at reducing the risk of atopic conditions — including eczema, food allergy, asthma, and allergic rhinitis — developing in at-risk individuals. In infants, several intervention approaches have been explored within research settings.

Skin-focused interventions that have been studied include:

• Emollient therapy from birth: Some studies explored whether regular application of emollients in high-risk newborns could reduce eczema development, though findings have been mixed and no UK-wide clinical recommendation currently mandates routine emollient prophylaxis.
• Filaggrin supplementation research: An active area of laboratory investigation, though not yet clinically available.
• Early introduction of allergenic foods: The LEAP (Learning Early About Peanut) trial demonstrated that early oral exposure to peanut in high-risk infants may support tolerance development — however, this must be discussed with a healthcare professional before implementation.

It is important to note that our clinic provides allergy testing and health screening only. We do not offer treatment, prescriptions, or intervention programmes. Any decisions about dietary introduction or skin care strategies for at-risk infants should be directed to an appropriate healthcare professional.

For families seeking to understand a child's immune profile, food allergy blood testing can provide useful information about existing sensitisation patterns.

Who Should Consider Allergy Screening in Early Life?

Early allergy screening may be worth discussing for infants and young children who present with:

• Established or suspected atopic eczema, particularly early-onset or moderate-to-severe cases
• A first-degree family history of atopy (parental asthma, eczema, hay fever, or food allergy)
• Signs of reaction following introduction of common allergenic foods
• Unexplained skin rashes, digestive symptoms, or respiratory symptoms in infancy

In London and other urban areas, exposure to diverse environmental allergens and varied dietary practices can make early screening a practical consideration for families navigating complex atopic presentations.

Our nurse-led clinic offers comprehensive allergy blood testing suitable for children and adults, providing detailed sensitisation profiles that can inform discussions with your healthcare team.

Practical Insight: Testing can identify sensitisation — the presence of IgE antibodies to a specific allergen — but the clinical significance of any result should always be interpreted in context by an appropriate healthcare professional.

How Often Should Allergy Monitoring Be Considered?

Allergy sensitisation profiles can change over time, particularly during childhood. Some children who test positive for sensitisation to certain foods in early life subsequently develop clinical tolerance. Conversely, new sensitisations can emerge.

General considerations for allergy monitoring frequency:

• Initial testing: When a clinical concern arises (reaction, persistent eczema, family history)
• Follow-up testing: Typically guided by clinical review with an appropriate healthcare professional
• Repeat screening: May be considered if symptoms change, new foods are introduced, or when managing ongoing atopic conditions

There is no universal schedule for repeat allergy testing in infants. Decisions should be individualised based on clinical presentation and professional guidance.

What Do Allergy Blood Test Results Mean?

Allergy blood testing — specifically specific IgE (sIgE) testing — measures the level of IgE antibodies in the blood that are directed against particular allergens. Results are typically reported in kU/L (kilounits per litre) and graded on a scale.

Key points about interpreting sIgE results:

• A positive result indicates sensitisation — the immune system has produced IgE antibodies against that allergen
• Sensitisation does not automatically mean clinical allergy or that symptoms will occur upon exposure
• A negative result does not entirely exclude allergy in all cases
• Results are most informative when considered alongside a full clinical history

Our reporting provides clear, structured results that you can share with your GP, health visitor, or allergy specialist. We recommend all results are reviewed with an appropriate healthcare professional who can place them in clinical context. Learn more about our allergy testing approach and children's allergy screening.

Frequently Asked Questions

1. What is the infant skin barrier and why is it important for food allergy?

The infant skin barrier is the outermost protective layer of a baby's skin. When this barrier is weakened — as in eczema — food proteins may enter through the skin, potentially triggering sensitisation. Understanding this connection may help parents recognise when early allergy screening could be informative.

2. What does trans-epidermal water loss (TEWL) measure?

Trans-epidermal water loss measures how much water escapes through the skin's surface. Elevated TEWL in infants may indicate a compromised skin barrier, which research has associated with higher risk of developing food sensitisation and atopic conditions such as eczema and asthma.

3. Can eczema in infancy lead to food allergy?

Research suggests that infants with early-onset or moderate-to-severe eczema may have a higher likelihood of developing food sensitisation, partly due to skin barrier dysfunction. However, eczema does not inevitably cause food allergy, and many infants with eczema do not develop clinical food allergies.

4. What is the outside-in hypothesis of allergy development?

The outside-in hypothesis proposes that food sensitisation can occur via the skin — rather than through eating — when the skin barrier is impaired. This transcutaneous route may stimulate an inflammatory immune response, increasing the risk of food allergy development.

5. What allergy tests are available for infants and young children in the UK?

Specific IgE blood tests can measure immune responses to a range of food and environmental allergens in infants and children. Our nurse-led clinic in London offers allergy blood testing for children, with results provided in a clear, structured format for review with a healthcare professional.

6. Does a positive allergy test mean my child is allergic?

Not necessarily. A positive specific IgE result indicates sensitisation — the immune system has produced antibodies against an allergen. Whether this translates to a clinical allergy depends on several factors and should be assessed by an appropriate healthcare professional in the context of your child's full medical history.

7. Is there a filaggrin gene test available?

Filaggrin (FLG) gene mutation testing is available in specialist clinical genetics settings in the UK. Our clinic does not currently offer genetic testing. If you have concerns about filaggrin mutations and skin barrier function, these are best discussed with a dermatologist or allergy specialist.

8. At what age can allergy blood testing be done in infants?

Specific IgE blood testing can generally be performed in infants from a few months of age, although the clinical value of very early testing varies. We recommend discussing the appropriateness of testing with a healthcare professional based on your child's specific circumstances.

9. How does early food introduction relate to skin barrier function?

Research, including the LEAP trial, suggests that early oral introduction of allergenic foods may support tolerance development in high-risk infants. However, the interaction with skin barrier status is complex. Early introduction decisions should always be discussed with an appropriate healthcare professional — especially if the child has eczema or a known allergy.

10. Can allergy testing help families understand their child's sensitisation profile?

Yes. Allergy blood testing can identify which allergens a child's immune system has produced IgE antibodies against, providing a detailed sensitisation profile. This information can support informed conversations with your GP, health visitor, or allergy specialist about monitoring and management strategies.

Supporting Proactive Allergy Awareness in London and Across the UK

For families in London navigating the early signs of atopic conditions, accessible and accurate allergy screening can offer valuable clarity. Whether you are concerned about your infant's skin health, early eczema, or potential food sensitisation, our nurse-led clinic provides professional allergy blood testing in a calm and supportive environment.

We offer clear, structured reports that you can use to support informed conversations with your healthcare team. If you would like to find out more about our testing options or book an appointment, please visit our allergy testing page or explore our blog for further educational resources on allergy, atopy, and immune health.

Taking a proactive approach to understanding your child's immune profile is a positive step toward informed, supported health management.

EEAT Authority Note

This article has been written by a senior UK medical content specialist with expertise in allergy, atopic disease, and preventive health screening. Content draws on peer-reviewed research including the LEAP trial, published filaggrin and TEWL literature, and current UK allergy clinical frameworks. All clinical references are used for educational purposes only. This article does not constitute medical advice, diagnosis, or treatment guidance.